Compositions and methods with enhanced therapeutic activity

Details for Australian Patent Application No. 2004218412 (hide)

Owner Oxigene, Inc.

Inventors Edvardsen, Klaus; Prezioso, Joseph Anthony; Wood, Mark; Chaplin, David J.; Pinney, Kevin G.

Agent Cullen & Co

Pub. Number AU-A-2004218412

PCT Pub. Number WO2004/078126

Priority 60/467,486 02.05.03 US; 60/450,565 28.02.03 US

Filing date 1 March 2004

Wipo publication date 16 September 2004

International Classifications

A61K 031/075 - Ethers or acetals

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/078126 Priority application(s): WO2004/078126

15 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218414-Tissue processing system

2004218411-Aerosol antiperspirant with polyamide